Technology

Transforming the treatment of structural heart disease

SEPTAL MYOTOMY

Pioneering a widely accessible interventional solution for hypertrophic cardiomyopathy patients

Limited accessible treatment options are currently available for patients with hypertrophic cardiomyopathy where a thickened septum partially blocks the outflow tract and obstructs blood flow from the left ventricle to the aorta.

Myotomy Solution

Transfemoral access

Leverages proven efficacy of lacerating hypertrophied septum

Purpose-built to orient, secure, & control laceration for fast repeatable procedure

Warning: Septal Solutions is a development stage company and the Myotomy solution is not approved by the FDA.